This Biotech Is Selling Birth Control — For Rats

Image Source: Grok
 

Introduction

Evolve® Rodent Birth Control™, made by SenesTech, is designed to stop the rapid reproduction of rats - just two rats in one year can become 15,000 - without the collateral damage to dogs, coyotes, foxes and birds of prey that comes with using rodenticides. This article provides some insight into the rat birth control concept.


About SenesTech Inc.

SenesTech Inc. (SNES) is a micro‑cap (just $12.2M) biotech company with birth‑control products for rats and mice. Its products - soft bait, in sausage form -attract rodents without harming the rodents, people or pets in the process.


How Bad is the Rat/Mouse Problem In the U.S.?

Data says 11.6% of all U.S. homes show signs of rodent infestation — that’s more than 1 in 10 households. Chicago remains the most rat‑infested city in the U.S. (10 years running) while East Coast cities like New York, Philadelphia, Washington D.C., Baltimore, and Pittsburgh are major hotspots and, interestingly, Los Angeles recently overtook Chicago in some rankings, showing the problem is spreading westward.


What Is the Total Addressable Market Size Of Rat/Mouse Control Products America?

According to Statista, the total addressable market (TAM)  size of rat/mouse control products (including traps, rodenticides, birth-control bait/stations and devices) currently is estimated to range from $1.5B to $2.5B and will grow to somewhere between $2.5B and $4.0B by 2030.


Is SenesTech's Product Safe? How Does It Work?

Evolve - made from non-hazardous ingredients like cottonseed oil - which decreases sperm production and ovarian follicle growth in rats and mice - is a soft bait that has been exempted by the Environmental Protection Agency (EPA) from the requirement that it be registered by the Federal Insecticide, Fungicide, and Rodenticide Act (FIFRA) Section 25(b) since it poses little or no risk to people or the environment, including non-target animals.


Who Are SenesTech's Competitors?

SenesTech has no true “direct” competitors in the fertility‑control niche.


Strategic Positioning

The markets for SenesTech products are municipalities, retailers, pest management professionals, the e-commerce sector and the international marketplace.

  1. Municipalities: 
    • The rodent situation in the U.S. is significant, widespread, and getting worse, particularly in cold‑weather regions as winter dramatically increases infestations as rats and mice move indoors for warmth and food. Of the approximately 19,000 municipalities in the U.S. (specifically cities, towns, villages, boroughs) 4,200 are in cold-weather states.
    • In a June 25, 2025 press release, SenesTech detailed a successful field trial conducted with the Irvine Campus Housing Authority at UC Irvine which showed that the rat population declined to the extent that  rodenticides were fully eliminated from all  bait stations deployed across common areas, demonstrating practical efficacy.
    • California has significantly restricted rodenticides, banning most uses under recent legislation to protect wildlife, with only limited exemptions for agriculture and public health emergencies and this regulatory shift puts products like Evolve in a favorable position as consumers and municipalities seek compliant, non-lethal options.
    • Municipal revenue grew 139% year-over-year due to expanded deployments in New York City, Chicago, and other locations, reflecting increased adoption in diverse urban settings. Current programs continue to focus on controlled deployments in high-impact areas, laying the groundwork for potential large-scale expansion. 
  2. Retailers: Retail revenue grew 254% year-over-year, driven by expanded adoption by Ace Hardware, and follow-on orders from Bradley Caldwell, a wholesaler serving over 8,000 retail locations in the Northeast.
  3. Pest management professionals: Pest management professionals boosted company revenue by 29% year-over-year and 72% sequentially, and now represents nearly 20% of the Company's overall Q3 2025 revenue,
  4. e-commerce sector: Evolve became available across several major online retail platforms during the year, including Tractor Supply Co., (TSCO) Home Depot (HD), Lowe’s (LOW), Amazon (AMZN), Walmart (WMT), and Ace Hardware, which materially broadened consumer access to the product. in total, the revenue of the e-commerce sector accounted for 54% of quarterly revenue
  5. International market: Evolve has entered the international market with shipments to Hong Kong, the Netherlands, Belize and the Maldives, with plans for Australia and New Zealand.


Why Is SenesTech Being Sued By Liphatech?

Liphatech, a major rodenticide manufacturer, sued SenesTech for a breach‑of‑contract under 28 U.S.C. §1332 Diversity – Breach of Contract in December, 2024, alleging that SenesTech violated terms of an agreement between the two companies, the specific details of which are currently unknown.

Editors' note: The Company believes the case is without merit and is actively defending the case.



SenesTech Financials

SenesTech has reported consistent revenue growth during the past 3 quarters going up 9.5% in Q3, 2025, to $690K, representing a 44% increase YoY, driven almost entirely by its EVOLVE rodent birth‑control line which accounted for 79% of sales in Q1 and 85% in Q3. Gross Profit went up 39% during the same period thanks to a healthy Gross Margin of 63% although its adjusted EBITDA loss, which closely tracks their cash utilization, was $1.32  million which is the best in the company's history. According to management, the balance sheet cash position of $10.2M has the ability to allow the company to reach profitability without proactively raising any additional dilutive capital but doesn’t solve the path to profitability.


SenesTech Stock Performance

SNES stock has declined 65.6% in the past 6 months but has only gone DOWN 13.8% in the past month.


Conclusion

While SNES is a potentially awesome long‑term investment given its lack of competition, it is highly speculative as its market cap remains very small, which typically implies high volatility and elevated dilution risk, and its low liquidity, sparse analyst coverage and long history of price decline. The key variables of its on-going success depend on management's execution of its marketing plan, the adoption of its unique concept by the sectors constituents and its access to capital. Of late, they have been doing an admirable job.


Related Articles:
SenesTech's 43% Revenue Surge That Nobody's Talking About
SenesTech Remains Undervalued With Increasing Revenues And Global Product Distribution
SenesTech's Big Play On Small Pests
SenesTech Has Built A Better Mouse Trap

More By This Author:
Only 2 Greenland Mining Companies Are Operational And Neither Is American Domiciled. Why Is That?
My Attendance At This Year's World Economic Forum - "All Is Good"
Trump's Noise About Seizing Greenland Has Caused The Stocks Of The Mining Companies Operating There To Jump In Price

This article is part of a new “UnderCovered” series of exclusive articles featuring companies with limited coverage. Authors are compensated by TalkMarkets for their time, and otherwise ...

more
How did you like this article? Let us know so we can better customize your reading experience.

Comments

Leave a comment to automatically be entered into our contest to win a free Echo Show.
John Doe 1 hour ago Member's comment
Thanks for putting this cmpany on my radar. I never heard of it before. But I see quoite a few authors have been writing about it here. Sounds like a great risk reward ratio as $SNES stock seems quite undervalued to me. Defintely worth a speculative investment.
Backyard Hiker 1 hour ago Member's comment
Is this FDA approved?
Alpha Stockman 1 hour ago Member's comment
This isn't human food. I don't even think the FDA approves pet food.
Bindi Dhaduk 1 hour ago Member's comment
It's better than food - iot will stop the rodents from eating YOUR food and multiplying.
Gil Richards 1 hour ago Member's comment
$SNES sounds like a good investment opportunity.
Frank Underwood 1 hour ago Member's comment
I own a couple of apartment buildings. Would love to use this for residential use, but I see that most of the revenue will likely be generated by places like restaurants, supermarkets, warehouses, amusement parks and municipalities.
Ayelet Wolf 1 hour ago Member's comment
After the tragic death of Flaco the owl in NYC due to rat poison, this feels like a necessary shift. Moving toward non-lethal, non-toxic alternatives isn't just about 'being nice' to rats—it's about protecting the hawks, owls, and family pets that accidentally ingest traditional poisons. I’d love to see more data on the 'secondary exposure' risks of this product, but from everything I've read here and in previous articles, it sounds like there is none.
My Stock Tips 1 hour ago Member's comment
The scalability here is fascinating. Traditional pest control is a multi-billion dollar industry built on recurring lethal treatments. I would think it goes without saying that birth control approach is more cost-effective for cities in the long run. Or is the high cost of specialized bait still a barrier to mass adoption? How much will it cost cities?
Alexis Renault 1 hour ago Member's comment
Interesting question. I also wonder though, what happens when every city starts using SenesTech birth control solutions, and rodents are effectively wiped out? What Senestech put themselves out of business?
My Stock Tips 1 hour ago Member's comment
If that actually hapened, Senestech and everyone who invested in them would be too rich to care. And they could always pivot into other related products.
Alexis Renault 1 hour ago Member's comment
Could the rats develop some sort of immunity or tolerance towrads the product, reducing its efficacy?
My Stock Tips 1 hour ago Member's comment
Ask the CEO of SenesTech - Joel Fruendt. He's on this site: https://talkmarkets.com/member/Joel-Fruendt
Old Time Investor 2 hours ago Member's comment
Interesting approach—fertility control seems like a more sustainable long-term solution than poisons. The key question is whether adoption can scale fast enough to matter financially.
Keith Lewis 2 hours ago Member's comment
I assume the company knows their product works, but how can cities measure rodent populations to see what kind of reduction there is?
Michele Grant 2 hours ago Member's comment
This is a great idea for ESG investors. But it also sounds quite novel and entering some unchartered territory. What are the biggest regulatory or adoption hurdles for fertility control versus poisons, and how long before this meaningfully impacts revenue?